Intensity-modulated radiation therapy: supportive data for prostate cancer

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Intensity-modulated radiation therapy (IMRT) has become the standard external-beam radiotherapy for localized prostate cancer since the mid-1990s.
• High radiation doses are crucial for achieving a cure in prostate cancer treatment.
• IMRT offers dosimetric advantages over conventional methods, enabling conformal dose distributions and organ sparing.

Purpose of the Study:

• To review the clinical data supporting Intensity-modulated radiation therapy (IMRT) for prostate cancer.
• To highlight the technical aspects of IMRT treatment planning and implementation.
• To discuss the safety and efficacy of IMRT in delivering high-dose irradiation to the prostate and regional lymph nodes.

Main Methods:

• Review of clinical studies and technical literature on Intensity-modulated radiation therapy (IMRT).
• Analysis of dosimetric superiority and organ-sparing capabilities of IMRT.
• Examination of advances in imaging and onboard verification systems for IMRT.

Main Results:

• IMRT is confirmed as the most effective and widely used radiotherapy for localized prostate cancer.
• IMRT demonstrates dosimetric superiority, allowing for conformal dose distributions and improved organ sparing.
• IMRT is recognized as the safest method for delivering high doses of external-beam irradiation to the prostate and lymph nodes.

Conclusions:

• Intensity-modulated radiation therapy (IMRT) is the preferred radiotherapy modality for localized prostate cancer due to its efficacy and safety.
• Technological advancements in IMRT hold promise for further dose escalation and hypofractionated treatment regimens.
• The review underscores the importance of IMRT in achieving high cure rates while minimizing toxicity in prostate cancer management.